HLA Typing Market By Product (Reagents & Consumables, Instruments, Software & Services), By Technology (Molecular Assay Technologies and Non-Molecular Assay Technologies), By Application (Diagnostic Applications and Research Applications), By End-Users (Independent Reference Laboratories, Hospitals & Transplant Centers, Research Laboratories & Academic Institutes), Geography (North America, Europe, APAC, RoW) Forecast up to 2026
HLA (Human Leukocyte Antigen) Typing is a kind of genetic test conducted to check individual differences in an immune system of the person. This test is important to identify whether a person is capable to safely donate bone marrow, cord blood, or any other organ to any person who is in need of a transplant. There is a rapid growth in the demand for transplant diagnostic products due to factors such as public and private increased funding in target research activities.
Click Here to Download Sample Report >> https://www.sdki.jp/sample-request-107558
Majorly the increase in certain diseases such as blood cancers, genetic blood disorders where stem cell transplantation is required, this situation is expected to drive the HLA Typing market. However, the limited reimbursements for target procedures are a restrain for this market. The HLA typing market is expected to reach USD 990.12 million by 2026 from USD 659.75 million in 2020, at a CAGR of ~7.0%.
The HLA typing market has been analyzed by utilizing the optimum combination of secondary sources and in-house methodology, along with an irreplaceable blend of primary insights. The real-time assessment of the market is an integral part of our market sizing and forecasting methodology. Our industry experts and panel of primary participants have helped in compiling relevant aspects with realistic parametric estimations for a comprehensive study. The participation share of different categories of primary participants is given below: